GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Preferred Stock

Invictus MD Strategies (Invictus MD Strategies) Preferred Stock : $0.00 Mil (As of Oct. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Preferred Stock?

Preferred stock is a special equity security that has properties of both equity and debt. Invictus MD Strategies's preferred stock for the quarter that ended in Oct. 2019 was $0.00 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Invictus MD Strategies's Enterprise Value for the quarter that ended in Oct. 2019 was $21.78 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Invictus MD Strategies's Book Value per Share for the quarter that ended in Oct. 2019 was $0.57.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Invictus MD Strategies's Earnings per Share (Diluted) for the three months ended in Oct. 2019 was $-0.04.


Invictus MD Strategies Preferred Stock Historical Data

The historical data trend for Invictus MD Strategies's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Preferred Stock Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Preferred Stock
- - - - -

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Invictus MD Strategies Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.


Invictus MD Strategies  (OTCPK:IVITF) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Invictus MD Strategies's Enterprise Value for the quarter that ended in Oct. 2019 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Invictus MD Strategies's Book Value per Share for the quarter that ended in Oct. 2019 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Invictus MD Strategies's Earnings per Share (Diluted) (EPS) for the three months ended in Oct. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invictus MD Strategies Preferred Stock Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

By Marketwired Marketwired 10-17-2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

By Marketwired Marketwired 08-14-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

By Marketwired Marketwired 06-26-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By Marketwired Marketwired 12-14-2019

Invictus announces Annual General Meeting Date

By Marketwired Marketwired 06-20-2019

INVICTUS ANNOUNCES RESIGNATIONS

By Marketwired Marketwired 12-06-2019